Organization · Venture Capital
Kunlun Capital
Kunlun Capital is a venture capital firm based in China, founded in 2015. It focuses on investing in technology-driven innovative enterprises, supporting entrepreneurial teams with global potential.
Overview
What Kunlun Capital does
What Kunlun Capital is
Kunlun Capital is a venture capital firm based in China, founded in 2015. It focuses on investing in technology-driven innovative enterprises, supporting entrepreneurial teams with global potential.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- February 28, 2026
Official channels
Find Kunlun Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Kunlun Capital as a funder
Investment thesis
Building innovative technology companies with founding teams that have globalization potential and localization capabilities
Focus narrative
Hardware technology, biomedicine, enterprise services, and consumer solutions. Early-stage venture in China, particularly Shanghai, Beijing, Jiangsu regions.
Value beyond capital
Deep expertise in technology and healthcare. Leverages Kunlun Group ecosystem. Focus on identifying subsector leaders with global scaling potential.
Terms and economics
- Typical check
- $20,000,000–$45,400,000
- Sweet spot
- $32,500,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 35
- Investments in the last 12 months
- 1
- Last recorded investment
- October 11, 2024
- Recorded notable exits
- Pony.ai, Cytek Biosciences, Biotheus, Kopi Kenangan, and PingCAP
Portfolio context
35 companies. Pony.ai (NASDAQ IPO, $3.48B), Cytek Biosciences (NASDAQ IPO), Biotheus (acquired by BioNTech for $800M), PingCAP (unicorn), Kopi Kenangan (unicorn).
Common questions
What to know about Kunlun Capital
Upseed classifies Kunlun Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
February 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.